337 related articles for article (PubMed ID: 22937879)
1. Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons.
Balestra B; Vicini R; Cremon C; Zecchi L; Dothel G; Vasina V; De Giorgio R; Paccapelo A; Pastoris O; Stanghellini V; Corinaldesi R; De Ponti F; Tonini M; Barbara G
Neurogastroenterol Motil; 2012 Dec; 24(12):1118-e570. PubMed ID: 22937879
[TBL] [Abstract][Full Text] [Related]
2. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome.
Barbara G; Wang B; Stanghellini V; de Giorgio R; Cremon C; Di Nardo G; Trevisani M; Campi B; Geppetti P; Tonini M; Bunnett NW; Grundy D; Corinaldesi R
Gastroenterology; 2007 Jan; 132(1):26-37. PubMed ID: 17241857
[TBL] [Abstract][Full Text] [Related]
3. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome.
Cremon C; Carini G; Wang B; Vasina V; Cogliandro RF; De Giorgio R; Stanghellini V; Grundy D; Tonini M; De Ponti F; Corinaldesi R; Barbara G
Am J Gastroenterol; 2011 Jul; 106(7):1290-8. PubMed ID: 21427712
[TBL] [Abstract][Full Text] [Related]
4. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
Buhner S; Li Q; Vignali S; Barbara G; De Giorgio R; Stanghellini V; Cremon C; Zeller F; Langer R; Daniel H; Michel K; Schemann M
Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012
[TBL] [Abstract][Full Text] [Related]
5. Submucous rather than myenteric neurons are activated by mucosal biopsy supernatants from irritable bowel syndrome patients.
Buhner S; Li Q; Berger T; Vignali S; Barbara G; De Giorgio R; Stanghellini V; Schemann M
Neurogastroenterol Motil; 2012 Dec; 24(12):1134-e572. PubMed ID: 22963673
[TBL] [Abstract][Full Text] [Related]
6. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
Park JH; Rhee PL; Kim HS; Lee JH; Kim YH; Kim JJ; Rhee JC
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815
[TBL] [Abstract][Full Text] [Related]
7. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship?
Braak B; Klooker TK; Wouters MM; Welting O; van der Loos CM; Stanisor OI; van Diest S; van den Wijngaard RM; Boeckxstaens GE
Am J Gastroenterol; 2012 May; 107(5):715-26. PubMed ID: 22488080
[TBL] [Abstract][Full Text] [Related]
8. Protease activated receptor 4 status of mast cells in post infectious irritable bowel syndrome.
Han W; Wang Z; Lu X; Guo C
Neurogastroenterol Motil; 2012 Feb; 24(2):113-9, e82. PubMed ID: 22151913
[TBL] [Abstract][Full Text] [Related]
9. Irritable bowel syndrome: is the colonic mucosa to blame?
Hoffman JM
Neurogastroenterol Motil; 2012 Dec; 24(12):1051-3. PubMed ID: 23176660
[TBL] [Abstract][Full Text] [Related]
10. Nerve growth factor content is increased in the rectal mucosa of children with diarrhea-predominant irritable bowel syndrome.
Willot S; Gauthier C; Patey N; Faure C
Neurogastroenterol Motil; 2012 Aug; 24(8):734-9, e347. PubMed ID: 22625872
[TBL] [Abstract][Full Text] [Related]
11. Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome.
Dothel G; Barbaro MR; Boudin H; Vasina V; Cremon C; Gargano L; Bellacosa L; De Giorgio R; Le Berre-Scoul C; Aubert P; Neunlist M; De Ponti F; Stanghellini V; Barbara G
Gastroenterology; 2015 May; 148(5):1002-1011.e4. PubMed ID: 25655556
[TBL] [Abstract][Full Text] [Related]
12. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
Martínez C; Lobo B; Pigrau M; Ramos L; González-Castro AM; Alonso C; Guilarte M; Guilá M; de Torres I; Azpiroz F; Santos J; Vicario M
Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702
[TBL] [Abstract][Full Text] [Related]
13. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.
Piche T; Barbara G; Aubert P; Bruley des Varannes S; Dainese R; Nano JL; Cremon C; Stanghellini V; De Giorgio R; Galmiche JP; Neunlist M
Gut; 2009 Feb; 58(2):196-201. PubMed ID: 18824556
[TBL] [Abstract][Full Text] [Related]
14. Combination of allergic factors can worsen diarrheic irritable bowel syndrome: role of barrier defects and mast cells.
Vivinus-Nébot M; Dainese R; Anty R; Saint-Paul MC; Nano JL; Gonthier N; Marjoux S; Frin-Mathy G; Bernard G; Hébuterne X; Tran A; Theodorou V; Piche T
Am J Gastroenterol; 2012 Jan; 107(1):75-81. PubMed ID: 21931380
[TBL] [Abstract][Full Text] [Related]
15. Immune derived opioidergic inhibition of viscerosensory afferents is decreased in Irritable Bowel Syndrome patients.
Hughes PA; Moretta M; Lim A; Grasby DJ; Bird D; Brierley SM; Liebregts T; Adam B; Blackshaw LA; Holtmann G; Bampton P; Hoffmann P; Andrews JM; Zola H; Krumbiegel D
Brain Behav Immun; 2014 Nov; 42():191-203. PubMed ID: 25063707
[TBL] [Abstract][Full Text] [Related]
16. Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome.
Piche T; Saint-Paul MC; Dainese R; Marine-Barjoan E; Iannelli A; Montoya ML; Peyron JF; Czerucka D; Cherikh F; Filippi J; Tran A; Hébuterne X
Gut; 2008 Apr; 57(4):468-73. PubMed ID: 18194987
[TBL] [Abstract][Full Text] [Related]
17. Altered interaction between enteric glial cells and mast cells in the colon of women with irritable bowel syndrome.
Meira de-Faria F; Casado-Bedmar M; Mårten Lindqvist C; Jones MP; Walter SA; Keita ÅV
Neurogastroenterol Motil; 2021 Nov; 33(11):e14130. PubMed ID: 33797165
[TBL] [Abstract][Full Text] [Related]
18. Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS.
Di Nardo G; Barbara G; Cucchiara S; Cremon C; Shulman RJ; Isoldi S; Zecchi L; Drago L; Oliva S; Saulle R; Barbaro MR; Stronati L
Neurogastroenterol Motil; 2014 Feb; 26(2):196-204. PubMed ID: 24304324
[TBL] [Abstract][Full Text] [Related]
19. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
[TBL] [Abstract][Full Text] [Related]
20. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.
Cremon C; Gargano L; Morselli-Labate AM; Santini D; Cogliandro RF; De Giorgio R; Stanghellini V; Corinaldesi R; Barbara G
Am J Gastroenterol; 2009 Feb; 104(2):392-400. PubMed ID: 19174797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
